Reinsurance Group of America (RGA) Q1 2026 earnings review
Record First Quarter Driven by Financial Solutions and Favorable Claims
RGA delivered a highly profitable Q1, with Adjusted Operating EPS surging 23% YoY to $6.97. Net premiums grew 14.3% YoY to $4.6 billion. The bottom line was propelled by favorable economic claims across all global regions and a reversal in variable investment income, which pushed average portfolio yields up to 4.93%. However, the quarter wasn't flawless: the effective tax rate unexpectedly jumped to 24.4% due to valuation allowances, and the core U.S. Traditional segment saw earnings stagnate despite premium growth. Regardless, explosive momentum in Financial Solutions across the Americas and EMEA proves RGA's capital deployment strategy into asset-intensive blocks is paying off.
🐂 Bull Case
Pre-tax operating income in the U.S. & Latin America Financial Solutions segment accelerated, jumping 76% YoY to $118M, while EMEA Financial Solutions grew 42% to $128M.
Unlike mid-2025, which was plagued by U.S. group health claims volatility, Q1 2026 featured favorable economic claims experience across every single global region.
🐻 Bear Case
Despite Net Premiums remaining stable at $1.93B, U.S. & Latin America Traditional pre-tax income dropped slightly to $138M from $140M YoY, indicating underlying margin pressure.
The effective tax rate on adjusted operating income hit 24.4%, well above the target 22-23% range, driven by valuation allowances on tax credits.
⚖️ Verdict: 🟢
Bullish. Exceptional bottom-line beat driven by core underwriting discipline and higher investment yields, which easily absorbed the impact of a higher tax bill and sluggish U.S. Traditional margins.
Key Themes
Financial Solutions Engine is Accelerating
RGA's strategy to deploy capital into asset-intensive and longevity block transactions is accelerating returns. Pre-tax adjusted operating income in the U.S. & Latin America Financial Solutions segment surged 76% YoY to $118M. Simultaneously, EMEA Financial Solutions jumped 42% YoY to $128M, driven by recent new business and favorable overall experience. This proves the company's 'Creation Re' framework is successfully scaling high-return capital deployment.
Investment Yield Reversing Upward
After struggling with muted Variable Investment Income (VII) in late 2025, the macro environment provided a tailwind. Average investment yield reversed its downward trend, climbing to 4.93% from 4.64% a year ago. First-quarter investment income (excluding spread-based businesses) increased 19.3% YoY, heavily supported by a larger average invested asset base and higher earned yields.
Favorable Claims Across All Geographies
Claims experience was a massive tailwind. Management reported favorable economic claims experience across all regions. This is a crucial stabilizing factor compared to the volatility seen in 2025 (which ultimately forced RGA to exit the U.S. group healthcare business).
U.S. Traditional Profitability Decelerating
A concerning contradiction lies in the U.S. & Latin America Traditional segment. Management lauded 'favorable individual life claims experience', yet segment pre-tax adjusted operating income actually fell slightly to $138M from $140M YoY. With net premiums essentially flat ($1,932M vs $1,921M), this suggests that underlying expense pressures or business mix shifts are compressing margins despite the favorable claims environment.
Tax Rate Headwinds Reversing Guidance
The effective tax rate on adjusted operating income spiked to 24.4%. This is a sharp reversal from management's historically guided range of 22% to 23%. The company cited the jurisdictional mix of earnings and an increase in the valuation allowance on tax credits. If this structural shift persists, it will create an ongoing drag on EPS.
Corporate Segment Losses Remain Elevated
The Corporate and Other segment recorded a $65M pre-tax adjusted operating loss. While stable compared to the $70M loss in 25Q1, management explicitly noted this was 'unfavorable compared to the expected quarterly average run rate.' The drag was attributed to the timing of compensation expenses and slightly unfavorable variable investment income localized to this segment.
Other KPIs
Accelerating. Up 9% YoY from $153.80 in 25Q1. This clean metric strips out the extreme interest rate volatility trapped in accumulated other comprehensive income, proving that the underlying value creation engine remains strongly intact.
Stable. The company maintained its buyback cadence, returning $50 million to shareholders through common share repurchases in Q1, consistent with the Q4 2025 run rate and its new $500M authorization.
Accelerating. An 11% YoY increase from $777M in 25Q1, demonstrating sustained organic growth momentum in Asian markets despite moderate foreign currency tailwinds ($18M).
Guidance
Reversing. The Q1 2026 effective tax rate on operating income came in at 24.4%, breaking above the company's previously stated target range of 22-23%. Management will need to clarify if the valuation allowance on tax credits is a permanent impairment or a temporary timing issue.
Key Questions
U.S. Traditional Margin Compression
You reported favorable individual life claims in U.S. Traditional, yet pre-tax operating income fell slightly year-over-year. What specific expense lines or business mix shifts are compressing margins in this segment?
Tax Rate Permanence
The effective tax rate missed your 22-23% target range due to valuation allowances on tax credits. Should investors underwrite this 24%+ tax rate as the new normal for 2026, or was this a discrete Q1 event?
Financial Solutions Capital Deployment
Financial Solutions saw explosive growth in both the U.S. and EMEA. How much of this Q1 pre-tax income jump was driven by recent in-force block deployments versus the base accretion of older vintages?
Variable Investment Income Sustainability
VII was a drag in late 2025 but propelled yields higher this quarter. Given your previous assumptions of a muted 7% VII return for 2026, does Q1's performance change your outlook for alternative asset returns for the remainder of the year?